IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Acadia Pharmaceuticals, Inc.
Symbol: ACAD
Price: Last trade $35.23
Trade Date: 8/10
Shares: 5.7 million
Underwriter(s) J.P. Morgan, Goldman Sachs, BofA Merrill Lynch
Rating=Subscription Needed
Company: CyrusOne Inc.
Symbol: CONE
Price: Last trade $51.62
Description: Re-offer range $49.60-$51.00
Trade Date: 8/10
Shares: 6.8 million
Underwriter(s) Goldman Sachs, Morgan Stanley
Rating=Subscription Needed
Company: Cliffs Natural
Symbol: CLF
Price: Last trade $7.70
Trade Date: 8/11
Shares: 38.9 million
Underwriter(s) BofA Merrill Lynch, Credit Suisse, Goldman Sachs, Deutsche Bank Securities
Co Manager(s) PNC Capital Marktets, Citizens, Regions Securities, Credit Agricole, The Huntington Investment Co.
Rating=Subscription Needed
Company: Zimmer Biomet Holdings-BLOCK
Symbol: ZBH
Price: Last Trade $133.09
Description: Re-offer range $129.75-$131.00
Trade Date: 8/10
Shares: 7.4 million
Underwriter(s) Goldman Sachs, J.P. Morgan
Rating=Subscription Needed
Company: VWR Corporation-BLOCK
[Symbol: VWR
Price: Last Trade $30.34
Description: Re-offer range: $29.50-$30.00
Trade Date: 8/10
Shares: 8 million
Underwriter(s) BofA Merrill Lynch
Rating=Subscription Needed